Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167


Differences in virulence gene expression between human blood and stool Campylobacter coli clade 1 ST828CC isolates.

Johansson C, Nilsson A, Kaden R, Rautelin H.

Gut Pathog. 2019 Aug 1;11:42. doi: 10.1186/s13099-019-0322-9. eCollection 2019.


Staphylococcus argenteus and Staphylococcus schweitzeri are cytotoxic to human cells in vitro due to high expression of alpha-hemolysin Hla.

Johansson C, Rautelin H, Kaden R.

Virulence. 2019 Dec;10(1):502-510. doi: 10.1080/21505594.2019.1620062.


Campylobacter coli Clade 3 Isolates Induce Rapid Cell Death In Vitro.

Johansson C, Nilsson A, Kaden R, Rautelin H.

Appl Environ Microbiol. 2019 Feb 20;85(5). pii: e02993-18. doi: 10.1128/AEM.02993-18. Print 2019 Mar 1.


Enhanced Systemic Response of Matrix Metalloproteinases and Their Regulators in Campylobacter and Salmonella Patients.

Nilsson A, Tervahartiala T, Lennebratt D, Lannergård A, Sorsa T, Rautelin H.

Diagnostics (Basel). 2018 Dec 13;8(4). pii: E82. doi: 10.3390/diagnostics8040082.


Which methods are appropriate for the detection of Staphylococcus argenteus and is it worthwhile to distinguish S. argenteus from S. aureus?

Kaden R, Engstrand L, Rautelin H, Johansson C.

Infect Drug Resist. 2018 Nov 21;11:2335-2344. doi: 10.2147/IDR.S179390. eCollection 2018.


Survival of Campylobacter jejuni and Campylobacter coli water isolates in lake and well water.

Nilsson A, Johansson C, Skarp A, Kaden R, Bertilsson S, Rautelin H.

APMIS. 2018 Sep;126(9):762-770. doi: 10.1111/apm.12879.


Stool Microbiota Composition Differs in Patients with Stomach, Colon, and Rectal Neoplasms.

Youssef O, Lahti L, Kokkola A, Karla T, Tikkanen M, Ehsan H, Carpelan-Holmström M, Koskensalo S, Böhling T, Rautelin H, Puolakkainen P, Knuutila S, Sarhadi V.

Dig Dis Sci. 2018 Nov;63(11):2950-2958. doi: 10.1007/s10620-018-5190-5. Epub 2018 Jul 11.


Characterization of Swedish Campylobacter coli clade 2 and clade 3 water isolates.

Nilsson A, Skarp A, Johansson C, Kaden R, Engstrand L, Rautelin H.

Microbiologyopen. 2018 Aug;7(4):e00583. doi: 10.1002/mbo3.583. Epub 2018 Feb 9.


Genomic and phenotypic characteristics of Swedish C. jejuni water isolates.

Nilsson A, Johansson C, Skarp A, Kaden R, Engstrand L, Rautelin H.

PLoS One. 2017 Dec 7;12(12):e0189222. doi: 10.1371/journal.pone.0189222. eCollection 2017.


Accessory genetic content in Campylobacter jejuni ST21CC isolates from feces and blood.

Skarp CPA, Akinrinade O, Kaden R, Johansson C, Rautelin H.

Int J Med Microbiol. 2017 Jun;307(4-5):233-240. doi: 10.1016/j.ijmm.2017.04.001. Epub 2017 Apr 3.


Lipooligosaccharide locus classes and putative virulence genes among chicken and human Campylobacter jejuni isolates.

Ellström P, Hansson I, Nilsson A, Rautelin H, Olsson Engvall E.

BMC Microbiol. 2016 Nov 21;16(1):116.


Risk factors associated with Campylobacter detected by PCR in humans and animals in rural Cambodia.

Osbjer K, Boqvist S, Sokerya S, Chheng K, San S, Davun H, Rautelin H, Magnusson U.

Epidemiol Infect. 2016 Oct;144(14):2979-2988. Epub 2016 Jun 23.


Detection of Campylobacter in human and animal field samples in Cambodia.

Osbjer K, Tano E, Chhayheng L, Mac-Kwashie AO, Fernström LL, Ellström P, Sokerya S, Sokheng C, Mom V, Chheng K, San S, Davun H, Boqvist S, Rautelin H, Magnusson U.

APMIS. 2016 Jun;124(6):508-15. doi: 10.1111/apm.12531. Epub 2016 Mar 18.


Campylobacteriosis: the role of poultry meat.

Skarp CPA, Hänninen ML, Rautelin HIK.

Clin Microbiol Infect. 2016 Feb;22(2):103-109. doi: 10.1016/j.cmi.2015.11.019. Epub 2015 Dec 11. Review.


Comparative genomics and genome biology of invasive Campylobacter jejuni.

Skarp CP, Akinrinade O, Nilsson AJ, Ellström P, Myllykangas S, Rautelin H.

Sci Rep. 2015 Nov 25;5:17300. doi: 10.1038/srep17300.


Composition of human faecal microbiota in resistance to Campylobacter infection.

Kampmann C, Dicksved J, Engstrand L, Rautelin H.

Clin Microbiol Infect. 2016 Jan;22(1):61.e1-61.e8. doi: 10.1016/j.cmi.2015.09.004. Epub 2015 Sep 11.


Increase in the Prevalence of Atrophic Gastritis Among Adults Age 35 to 44 Years Old in Northern Sweden Between 1990 and 2009.

Song H, Held M, Sandin S, Rautelin H, Eliasson M, Söderberg S, Hallmans G, Engstrand L, Nyrén O, Ye W.

Clin Gastroenterol Hepatol. 2015 Sep;13(9):1592-600.e1. doi: 10.1016/j.cgh.2015.04.001. Epub 2015 Apr 6.


Multilocus sequence typing (MLST) and whole-genome MLST of Campylobacter jejuni isolates from human infections in three districts during a seasonal peak in Finland.

Kovanen SM, Kivistö RI, Rossi M, Schott T, Kärkkäinen UM, Tuuminen T, Uksila J, Rautelin H, Hänninen ML.

J Clin Microbiol. 2014 Dec;52(12):4147-54. doi: 10.1128/JCM.01959-14. Epub 2014 Sep 17.


Susceptibility to Campylobacter infection is associated with the species composition of the human fecal microbiota.

Dicksved J, Ellström P, Engstrand L, Rautelin H.

mBio. 2014 Sep 16;5(5):e01212-14. doi: 10.1128/mBio.01212-14.


A prospective follow-up study on transmission of Campylobacter from poultry to abattoir workers.

Ellström P, Hansson I, Söderström C, Engvall EO, Rautelin H.

Foodborne Pathog Dis. 2014 Sep;11(9):684-8. doi: 10.1089/fpd.2014.1753. Epub 2014 Jun 2.


Helicobacter pylori and gastrointestinal symptoms in diagnostics and adjuvant chemotherapy of colorectal cancer.

Soveri LM, Osterlund P, Ruotsalainen T, Poussa T, Rautelin H, Bono P.

Oncol Lett. 2014 Feb;7(2):553-559. Epub 2013 Nov 29.


Lipooligosaccharide locus class of Campylobacter jejuni: sialylation is not needed for invasive infection.

Ellström P, Feodoroff B, Hänninen ML, Rautelin H.

Clin Microbiol Infect. 2014 Jun;20(6):524-9. doi: 10.1111/1469-0691.12382. Epub 2013 Oct 29.


Clonal distribution and virulence of Campylobacter jejuni isolates in blood.

Feodoroff B, de Haan CP, Ellström P, Sarna S, Hänninen ML, Rautelin H.

Emerg Infect Dis. 2013 Oct;19(10):1653-5. doi: 10.3201/eid1910.121537.


Characterization of clinical Campylobacter jejuni isolates with special emphasis on lipooligosaccharide locus class, putative virulence factors and host response.

Ellström P, Feodoroff B, Hänninen ML, Rautelin H.

Int J Med Microbiol. 2013 Apr;303(3):134-9. doi: 10.1016/j.ijmm.2013.01.005. Epub 2013 Mar 6.


Finnish Campylobacter jejuni strains of multilocus sequence type ST-22 complex have two lineages with different characteristics.

Revez J, Rossi M, Ellström P, de Haan C, Rautelin H, Hänninen ML.

PLoS One. 2011;6(10):e26880. doi: 10.1371/journal.pone.0026880. Epub 2011 Oct 24.


Campylobacter jejuni isolates in Finnish patients differ according to the origin of infection.

Feodoroff B, Ellström P, Hyytiäinen H, Sarna S, Hänninen ML, Rautelin H.

Gut Pathog. 2010 Dec 20;2(1):22. doi: 10.1186/1757-4749-2-22.


Recent trends in primary antimicrobial resistance of Helicobacter pylori in Finland.

Kostamo P, Veijola L, Oksanen A, Sarna S, Rautelin H.

Int J Antimicrob Agents. 2011 Jan;37(1):22-5. doi: 10.1016/j.ijantimicag.2010.09.013. Epub 2010 Nov 16.


Assessment of systemic matrix metalloproteinase and their regulator response in children with Helicobacter pylori gastritis.

Rautelin H, Tervahartiala T, Lauhio A, Sorsa T, Kolho KL.

Scand J Clin Lab Invest. 2010 Nov;70(7):492-6. doi: 10.3109/00365513.2010.520732. Epub 2010 Sep 21.


Longitudinal analysis of serological responses of adults to Helicobacter pylori antigens.

Perez-Perez GI, Maw AM, Feingold-Link L, Gunn J, Bowers AL, Minano C, Rautelin H, Kosunen TU, Blaser MJ.

J Infect Dis. 2010 Sep 15;202(6):916-23. doi: 10.1086/655660.


Decreasing trend of overlapping multilocus sequence types between human and chicken Campylobacter jejuni isolates over a decade in Finland.

de Haan CP, Kivistö R, Hakkinen M, Rautelin H, Hänninen ML.

Appl Environ Microbiol. 2010 Aug;76(15):5228-36. doi: 10.1128/AEM.00581-10. Epub 2010 Jun 11.


Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: A cohort study.

Kosunen TU, Pukkala E, Sarna S, Seppälä K, Aromaa A, Knekt P, Rautelin H.

Int J Cancer. 2011 Jan 15;128(2):433-9. doi: 10.1002/ijc.25337. Epub 2010 Mar 22.


Characterization of multiple Helicobacter bizzozeronii isolates from a Finnish patient with severe dyspeptic symptoms and chronic active gastritis.

Kivistö R, Linros J, Rossi M, Rautelin H, Hänninen ML.

Helicobacter. 2010 Feb;15(1):58-66. doi: 10.1111/j.1523-5378.2009.00730.x.


A "screen-and-treat" approach for Helicobacter pylori infection: a population-based study in Vammala, Finland.

Salomaa-Räsänen A, Kosunen TU, Aromaa AR, Knekt P, Sarna S, Rautelin H.

Helicobacter. 2010 Feb;15(1):28-37. doi: 10.1111/j.1523-5378.2009.00727.x.


Immunogenetic characteristics of patients with autoimmune gastritis.

Oksanen AM, Haimila KE, Rautelin HI, Partanen JA.

World J Gastroenterol. 2010 Jan 21;16(3):354-8.


Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection.

Veijola LI, Oksanen AM, Sipponen PI, Rautelin HI.

World J Gastroenterol. 2010 Jan 7;16(1):83-8.


Patient-reported complications associated with Campylobacter jejuni infection.

Schönberg-Norio D, Mattila L, Lauhio A, Katila ML, Kaukoranta SS, Koskela M, Pajarre S, Uksila J, Eerola E, Sarna S, Rautelin H.

Epidemiol Infect. 2010 Jul;138(7):1004-11. doi: 10.1017/S0950268809991099. Epub 2009 Nov 4.


Milk protein IgG and IgA: the association with milk-induced gastrointestinal symptoms in adults.

Anthoni S, Savilahti E, Rautelin H, Kolho KL.

World J Gastroenterol. 2009 Oct 21;15(39):4915-8.


Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates.

Feodoroff FB, Lauhio AR, Sarna SJ, Hänninen ML, Rautelin HI.

Clin Microbiol Infect. 2009 Feb;15(2):188-92. doi: 10.1111/j.1469-0691.2008.02657.x. Epub 2009 Jan 10.


Elevated infection parameters and infection symptoms predict an acute coronary event.

Pesonen E, Andsberg E, Grubb A, Rautelin H, Meri S, Persson K, Puolakkainen M, Sarna S, Ohlin H.

Ther Adv Cardiovasc Dis. 2008 Dec;2(6):419-24. doi: 10.1177/1753944708098695.


Bovine Campylobacter jejuni strains differ from human and chicken strains in an analysis of certain molecular genetic markers.

Gonzalez M, Hakkinen M, Rautelin H, Hänninen ML.

Appl Environ Microbiol. 2009 Feb;75(4):1208-10. doi: 10.1128/AEM.01879-08. Epub 2008 Dec 19.


Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.

Rautelin HI, Oksanen AM, Veijola LI, Sipponen PI, Tervahartiala TI, Sorsa TA, Lauhio A.

Ann Med. 2009;41(3):208-15. doi: 10.1080/07853890802482452.


Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection.

Veijola L, Oksanen A, Sipponen P, Rautelin H.

Clin Vaccine Immunol. 2008 Nov;15(11):1705-10. doi: 10.1128/CVI.00165-08. Epub 2008 Sep 30.


Cure of Helicobacter pylori infection in all compliant patients: report on 644 subjects.

Seppälä K, Kosunen TU, Veijola L, Sipponen P, Arkkila PE, Rautelin H, Tilvis R.

Scand J Gastroenterol. 2008;43(9):1149-50. doi: 10.1080/00365520802078366. No abstract available.


Role of earlier gastroscopy in predicting findings on repeat gastroscopy in a population with a low H. pylori prevalence.

Oksanen A, Veijola L, Korudanova B, Sipponen P, Sarna S, Rautelin H.

Scand J Gastroenterol. 2008;43(9):1044-9. doi: 10.1080/00365520802078333.


Persisting chronic gastritis and elevated Helicobacter pylori antibodies after successful eradication therapy.

Veijola L, Oksanen A, Linnala A, Sipponen P, Rautelin H.

Helicobacter. 2007 Dec;12(6):605-8.


Detection of Helicobacter species in chronic liver disease and chronic inflammatory bowel disease.

Veijola L, Nilsson I, Halme L, Al-Soud WA, Mäkinen J, Ljungh A, Rautelin H.

Ann Med. 2007;39(7):554-60.


Evaluation of an enzyme immunoassay-based stool antigen test to detect Campylobacter jejuni and Campylobacter coli.

Tissari P, Rautelin H.

Diagn Microbiol Infect Dis. 2007 Jun;58(2):171-5. Epub 2007 Feb 14.


Evaluation of genetic markers and molecular typing methods for prediction of sources of Campylobacter jejuni and C. coli infections.

Kärenlampi R, Rautelin H, Hänninen ML.

Appl Environ Microbiol. 2007 Mar;73(5):1683-5. Epub 2007 Jan 12.


Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota.

Myllyluoma E, Ahlroos T, Veijola L, Rautelin H, Tynkkynen S, Korpela R.

Int J Antimicrob Agents. 2007 Jan;29(1):66-72. Epub 2006 Dec 1.


Supplemental Content

Loading ...
Support Center